Delivery Order SPE2DR25D3104-SPE2DR26FE9CA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,020.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $105,296 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with performance at the company's Conshohocken, Pennsylvania location. The contract employs firm fixed price pricing and carries an ultimate completion date of September 3, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to fulfill federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $81,575.20 under a firm fixed-price contract. The delivery order, issued on November 26, 2025, is scheduled for completion by December 18, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger contract vehicle, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance of this delivery order will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Varivax vaccine with diluents. This $19,839 firm fixed price delivery order is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the company's existing contract vehicle. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,032.11. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $190,672.68 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on December 2, 2025, carries an ultimate completion date of December 23, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,047.90 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9CADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.19 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, effective December 18, 2025, with an ultimate completion date of January 12, 2026. The award is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of vaccine and pharmaceutical deliveries across multiple therapeutic domains, positions it as a critical vendor supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/17/25 |